Eurofins Scient (OTCMKTS:ERFSF) and GoodRx (NASDAQ:GDRX) Financial Survey

GoodRx (NASDAQ:GDRX) and Eurofins Scient (OTCMKTS:ERFSF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk.

Profitability

This table compares GoodRx and Eurofins Scient’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GoodRx	3.82%	9.31%	4.38%
Eurofins Scient	N/A	N/A	N/A

Institutional and Insider Ownership

63.8% of GoodRx shares are owned by institutional investors. 4.5% of GoodRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

GoodRx has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Eurofins Scient has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for GoodRx and Eurofins Scient, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3	8	5	0	2.13
Eurofins Scient	0	3	1	0	2.25

GoodRx currently has a consensus price target of $3.98, indicating a potential upside of 94.18%. Given GoodRx’s higher possible upside, equities research analysts clearly believe GoodRx is more favorable than Eurofins Scient.

Earnings & Valuation

This table compares GoodRx and Eurofins Scient”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85 million	0.88	$30.44 million	$0.09	22.78
Eurofins Scient	$8.25 billion	1.80	$537.29 million	N/A	N/A

Eurofins Scient has higher revenue and earnings than GoodRx.

Summary

GoodRx beats Eurofins Scient on 8 of the 12 factors compared between the two stocks.

About GoodRx

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

About Eurofins Scient

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.